🇺🇸 Hepavax-Gene in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 6

Most-reported reactions

1. Cerebral Ventricle Dilatation — 1 report (16.67%)
2. Clonic Convulsion — 1 report (16.67%)
3. Electrolyte Imbalance — 1 report (16.67%)
4. Hydrocephalus — 1 report (16.67%)
5. Hyperkalaemia — 1 report (16.67%)
6. Retinopathy Of Prematurity — 1 report (16.67%)

Source database →

Frequently asked questions

Is Hepavax-Gene approved in United States?

Hepavax-Gene does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Hepavax-Gene in United States?

Chiang Mai University is the originator. The local marketing authorisation holder may differ — check the official source linked above.